Market news

Detailed price information for Clearpoint Neuro Inc (CLPT-Q) from The Globe and Mail including charting and trades.

Motley Fool Press Release.

Detailed price information for Keros Therapeutics Inc (KROS-Q) from The Globe and Mail including charting and trades.

Detailed price information for Clearpoint Neuro Inc (CLPT-Q) from The Globe and Mail including charting and trades.

U.S. stock futures rise on Tuesday, but Powell Industries Inc shares fall 13.4% after reporting lower-than-expected earnings and sales.

The headline numbers for ClearPoint Neuro (CLPT) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

ClearPoint Neuro (CLPT) delivered earnings and revenue surprises of -31.03% and -16.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

ClearPoint Neuro (NASDAQ:CLPT) reported second-quarter 2026 revenue growth while outlining a shift in investment priorities toward clinical capacity, preclinical laboratory services and technologies intended to support commercial-scale neuro drug delivery. Total revenue for the three months ended J

Positive BioPharma Partner Regulatory Progress and Early Success in Focused Ultrasound Technology Platform Expansion SOLANA BEACH, CA / ACCESS Newswire / August 3, 2026 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, ...

RMAT Designation Supports an Expedited FDA Development and Review Pathway for Aspen's Investigational Autologous Cell Replacement Therapy for Parkinson's Disease. SOLANA BEACH, CA / ACCESS Newswire / July 31, 2026 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) ...

SOLANA BEACH, CA / ACCESS Newswire / July 21, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that it will release ...